Both in Pharmaceuticals
Sunshine Biopharma vs PMGC Holdings
Over the past year SBFM returned −94.6% and ELAB returned −99.7%; their daily moves had a correlation of -0.01.
SBFM −94.6% ELAB −99.7%Growth of $1, one year, split-adjusted
| Metric | SBFM | ELAB |
|---|---|---|
| Price | $0.7874 | $3.67 |
| Market cap | $3.1M | $3.0M |
| Today | −3.73% | −23.22% |
| 1 month | −31.5% | −30.9% |
| 6 months | −92.2% | −89.7% |
| Year to date | −93.6% | −99.0% |
| 1 year | −94.6% | −99.7% |
| Revenue growth (YoY) | −1.6% | — |
| Gross margin | 26.2% | 29.5% |
| Net margin | −16.9% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.1× | 1.2× |
| Net cash | $13.7M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 82.1% | 677.5% |
| Short % of float | 1.0% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).